Interleukin-2 (IL-2) receptor α, β and γ subunit expression as a function of B-cell lineage ontogeny: The use of IL-2-PE66(4Glu) to characterize internalization via IL-2 receptor subunits

Scandinavian Journal of Immunology

Volumn 46, Issue 2, 1997, Pages 129-136

  Steinberger, I ^a   Ben Bassat, H ^b   Hochberg, E ^a   Lorberboum Galski, H ^a,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERNALIZATION; ONTOGENY; PRIORITY JOURNAL;

EID: 0030765937     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-101.x     Document Type: Article

References (40)

1. Taniguchi T, Mirami Y. The IL-2/IL-2 receptor system: A. current overview. Cell 1993;73:5-8.
2. Waldmann TA. The interleukin-2 receptor. J Biol Chem 1991; 266:2681-4.
3. Benveniste EN, Merrill JE. Stimulation of oligoendroglial proliferation and maturation by IL2. Nature 1986;321:610-13.
4. Tentori L, Longo DL, Zuniga-Pflucker JC, Wing C, Kruisbeek AM. Essential role of the interleukin 2-interleukin 2 receptor pathway in thymocyte maturation in vivo. J Exp Med 1988;168:1741-7.
5. Mingari MC, Gerosa F, Carra G et al. Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature 1984;312:641-3.
6. Waldmann TA, Goldman CK, Robb RJ et al. Expression of interleukin 2 receptors on activated human B cells. J Exp Med 1984;160:1450-66.
7. Leonard WJ, Depper JM, Crabtree JR. Molecular cloning and expression of cDNAs for human interleukin-2 receptor. Nature 1984;311:626-31.
8. Tsudo M, Kozak RW, Goldman CK, Waldmann TA. Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci USA 1986;83:9694-8.
9. Takeshita T, Ohtani K, Asao H, Kumaki S, Nakamura M, Sugamura K. An associated molecule, p64, with IL-2 receptor β chain: Its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex. J Immunol 1992;148:2154-8.
10. Waldmann TA. The IL-2/IL-2 receptor system: A target for rational immune inervention. Immunol Today 1993;14:264-70.
11. Arima N, Kamio M, Imada K et al. Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling. J Exp Med 1992;176:1265-72.
12. Minowada J, Sagawa K, Trowbridge IS, Kung PD, Goldstein G. Marker profile of 55 human leukemia lymphoma cell lines. In: Rosenberg S, Kaplan S, eds. Malignant lymphoma. New York: Academic Press 1982;53-74.
13. 4Glu: A new chimeric protein cytotoxic to human activated T lymphocytes. J Biol Chem 1990;265:16311-17.
14. Lorberboum-Galski H, Fitzgerald D, Chaudhary V, Adhya S, Pastan I. Cytotoxic activity of an interleukin2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli. Proc Natl Acad Sci USA 1988;85:1922-6.
15. Lorberboum-Galski H, Kozak RW, Waldmann TA, Bailon P, Fitzgerald DJP, Pastan I. IL2-PE40 is cytotoxic to cells displaying either the p55 or p70 subunit of the IL2 receptor. J Biol Chem 1988;263:18650-2.
16. Middlebrook JI, Dorland RB. Bacterial toxins: cellular mechanisms of action. Microbiol Rev 1984;48:199-21.
17. Lorberboum-Galski H. Interleukin 2-Pseudomonas exotoxin A (IL2-PE40) chimeric protein for targeted immunotherapy and the study of immune responses. J Toxicol-Toxin Revies 1994;13:105-9.
18. Leonard WJ, Depper JM, Uchiyma T, Smit KA, Waldmann TA, Greene WC. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature (London) 1982;300:267-9.
19. Klein G, Giovanella B, Westman A, Stehlin JS, Munford D. An EBV-genome-negative cell line established from an American Burkitt lymphoma, receptor characteristics, EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirol 1975;5:319-34.
20. Steinitz M, Klein G. EBV induced changes in the saturation sensitivity and serum dependence of established EBV-negative lymphoma lines in vitro. Virology 1976;70:570-3.
21. Pulvertaft FJV. A study of malignant tumors in Nigeria by short term tissue cell culture. J Clin Pathol 1965;18:261-71.
22. Ben-Bassat H, Goldblum N, Mitrani S et al. Establishment in continuous culture of a new type of lymphocyte from a 'Burkitt-like' malignant lymphoma (Line DG-75). Intl J Cancer 1977;19:27-33.
23. Henle G, Henle W, Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med 1968;128:1011-20.
24. Menczes J, Leibold W, Klein G, Clements G. Establishment of an EBV-negative lymphoblastoid B cell line (Bjab) from an exceptional EBV-genome negative African Burkitt's lymphoma. Biomedicine 1975;22:276-84.
25. Steinitz M, Klein G. Comparison between growth characteristic of an EBV-genom-negative lymphoma line and its EBV-converted subline in vitro. Proc Natl Acad Sci USA 1975;72:3518-20.
26. Burk KH, Drewinko B, Trujillo JM, Ahearn MJ. Establishment of a plasma cell line in vitro. Cancer Res 1978;38:2508-13.
27. Nilsson K, Bennich H, Johansson SGO, Ponten J. Established immunoglobulin producing myeoloma (IgE) and lymphoblastoid (IgD) cell lines from an IgE myeloma patient. Clin Exp Immunol 1970;7:477-89.
28. Ben-Bassat H, Goldblum T, Mitrani S, Bentwichz, Goldblum N. Con A receptors and other cell surface antigenic characteristics of continuous lymphoblastoid cell lines derived from patients with Hodgkin's disease and other malignant lymphomas. Proc Natl Acad Sci USA 1975;72:1046-9.
29. Fuqua SAW, Fitzgerald SD, McGuire WL. A simple polymerase chain reaction method for detection and cloning of low-abundance transcripts. BioTechniques 1990;9:206-11.
30. Hatakeyuma M, Tsudo M, Minamoto S et al. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human α and β cDNAs. Science 1989;244:551-6.
31. Takeshita T, Asao H, Ohtani K et al. Cloning of the γ chain of the human IL2 receptor. Science 1992;257:379-82.
32. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: Interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 1985;82:6133-7.
33. Bailon P, Weber DV, Gately M et al. Purification and partial characterization of an interleukin 2-Pseudomonas exotoxin fusion protein. Biotechnology 1988;6:1326-9.
34. Uckun FM (Review) Regulation of human B-cell ontogeny. Blood 1990;76:1908-23.
35. Tanaka T, Saiki O, Doi S, Suemura M, Negoro S, Kishimoto S. Expression of novel interleukin 2 binding molecules and their functional roles in human B-cell differentiation. J Clin Invest 1988;82:316-21.
36. Reinecker H-C, Podolsky D. Human intestinal epithelial cells express functional cytokine receptors sharing the common gc chain of the inerleukin 2 receptor. Proc Natl Acad Sci USA 1995;92:8353-7.
37. Dmoszynska A, Rolinski J. Interleukin 2 receptor (IL-2): structure and function. Acta Haematol Pol 1995;26:257-62.
38. Fujii M, Sugamura K, Sano K, Nakai M, Sugita K, Hinuma Y. High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells. J Exp Med 1986;163:550-62.
39. Voss SD, Leary TP, Sondel PM, Robb R. Identification of a direct interaction between interleukin 2 and the PGU interleukin 2 receptor γ chain. Proc Natl Acad Sci USA 1993;90:2428-32.
40. Nilsson K, Klein G. Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. Adv Cancer Res 1982;37:319-80.